# Stryker Invests $400M in CMR Surgical

> Stryker to invest $400m in CMR Surgical for U.S. sales rights and acquisition option.
- Title: Stryker Invests $400M in CMR Surgical · AI Insider | Shortify
- Summary: Stryker to invest $400m in CMR Surgical for U.S. sales rights and acquisition option. Stryker invests $400 million in CMR Surgical to gain U.S. sales rights…
- Keywords: stryker, cmr surgical, versius, surgical robotics, u.s. sales rights, acquisition option, preferred equity, technology, Invests, 400M, CMR, Surgical
- Source: AI Insider — https://theaiinsider.tech/2026/10/12/stryker-to-invest-400m-in-cmr-surgical-gains-u-s-sales-rights-and-acquisition-option
- Author: Greg Bock
- Published: 2026-10-12T15:48:45+00:00
- Read time: 1 min
- Topics: stryker, cmr surgical, versius, surgical robotics, u.s. sales rights, acquisition option, preferred equity, ai, technology
## Stryker to invest $400m in CMR Surgical
Stryker plans to invest approximately $400 million in British surgical robotics company CMR Surgical through a strategic alliance.
## Gains U.S. Sales Rights
Stryker gains exclusive U.S. sales rights to CMR’s Versius robotic surgery systems and an acquisition option.
## Preferred Equity Investment
The £300 million preferred equity investment supports Versius portfolio development and global commercialization.
## CMR’s Versius System
CMR’s second-generation Versius system uses modular design for soft-tissue surgical procedures in hospitals and ambulatory surgery centers.
## Strategic Alliance Details
Stryker serves as exclusive U.S. sales agent while CMR oversees product development outside the United States.
## Stryker’s Statement
Stryker’s Andy Pierce says the alliance combines complementary strengths for robotic-assisted surgery adoption.

> We have evaluated the segment carefully for years, and this alliance represents a thoughtful and disciplined entry that combines the complementary strengths of both companies
## CMR’s Statement
CMR’s CEO Massimiliano Colella says Stryker investment accelerates global Versius expansion and welcomes Andy Pierce to board.

> Stryker’s investment will give us additional strength to accelerate innovation and the continued global expansion of the Versius portfolio
## Key takeaway

Stryker invests $400 million in CMR Surgical to gain U.S. sales rights and an acquisition option for its Versius robotic surgery systems.